Researchers from Leiden University Medical Center (LUMC) and the Leiden-based biotech company Ncardia have joined forces to ...
Emerging cardiovascular technology, trends in ambulatory care, provider and payer partnerships, and value-based arrangements create strategic opportunities to address service demand and cost pressures ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. At Catholic Health, advanced technology is changing how we ...
News-Medical.Net on MSN
See through the skin: New technology spots early heart disease warning signs
Researchers from Helmholtz Munich and the Technical University of Munich (TUM) have developed "fast-RSOM", a new imaging ...
Innovation is a powerful tool. Especially in the field of medicine, where it can save lives. The latest advancement, a new generation of noninvasive scanners, allow physicians the capability to ...
Collinsville Fire Department in Illinois pioneers advanced ZOLL Zenix cardiac monitors, improving pre-hospital care and ...
Dallas, TX, Oct. 28, 2025 (GLOBE NEWSWIRE) -- PatentVest, the first fully integrated IP intelligence and strategy firm, has released its latest PatentVest Pulse report, “The State of Cardiac ...
There is an indisputable trend toward minimally invasive, outpatient procedures in healthcare. Outpatient procedures help to alleviate burdens on the healthcare system, save patients time, money, and ...
CHICAGO, Ill. (Ivanhoe Newswire) – This year, more than 356,000 people in the U.S. will experience a cardiac arrest – their heart will just stop. It’s caused by arrhythmias that prevent the heart from ...
Medtronic is acquiring Affera Inc., a medical technology company focused on treating cardiac arrhythmias, for $925 million. While Medtronic declined Monday to share the sale price, analysts at Piper ...
New solutions for improving and managing cardiovascular health are urgently needed, but effective and worthwhile solutions often fail to make it to patients because all critical stakeholders are not ...
Johnson & Johnson will spend $16.6 billion to buy cardiovascular technology company Abiomed to strengthen its medical device division.The health care giant said Tuesday that it will pay $380 for each ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results